相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade
Wei Yu Lin et al.
BLOOD (2007)
Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus
Min Ae Lee-Kirsch et al.
NATURE GENETICS (2007)
BAFF and MyD88 signals promote a lupuslike disease independent of T cells
Joanna R. Groom et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Crosstalk among Jak-STAT, toll-like receptor, and ITAM-dependent pathways in macrophage activation
Xiaoyu Hu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Selective blockade of the inhibitory Fcγ receptor (Fcγ RIIB) in human dendritic cells and monocytes induces a type I interferon response program
Kavita M. Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
mTOR at the crossroads of T cell proliferation and tolerance
Anna Mondino et al.
SEMINARS IN IMMUNOLOGY (2007)
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE
Jane Tian et al.
NATURE IMMUNOLOGY (2007)
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Holger Kanzler et al.
NATURE MEDICINE (2007)
Systemic lupus erythematosus-associated defects in the inhibitory receptor FcγRIIb reduce susceptibility to malaria
Menna R. Clatworthy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis
Iva Gunnarsson et al.
ARTHRITIS AND RHEUMATISM (2007)
Expression profile of FcγRIIB on leusocytes and its dysregulation in systemic lupus erythematosus
Kaihong Su et al.
JOURNAL OF IMMUNOLOGY (2007)
Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus
Xavier Valencia et al.
JOURNAL OF IMMUNOLOGY (2007)
Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance
Marc Ehlers et al.
TRENDS IN IMMUNOLOGY (2007)
Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors
Sean R. Christensen et al.
SEMINARS IN IMMUNOLOGY (2007)
Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab
Josette Carnahan et al.
MOLECULAR IMMUNOLOGY (2007)
The antiinflammatory activity of IgG: the intravenous IgG paradox
Falk Nimmerjahn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus
Martin Aringer et al.
ARTHRITIS AND RHEUMATISM (2007)
B cell depletion therapy in systemic lupus erythematosus: Longterm follow-up and predictors of response
Kristine P. Ng et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Natural regulatory T cells: mechanisms of suppression
Makoto Miyara et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Siglecs and their roles in the immune system
Paul R. Crocker et al.
NATURE REVIEWS IMMUNOLOGY (2007)
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Arlene H. Sharpe et al.
NATURE IMMUNOLOGY (2007)
Targeting BAFF: Immunomodulation for autoimmune diseases and lymphomas
Andrew P. R. Sutherland et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Systemic lupus erythematosus: all roads lead to type I interferons
Virginia Pascual et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway
Brian T. Fife et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis
Amy Bergtold et al.
JOURNAL OF IMMUNOLOGY (2006)
Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus
Bailin Liang et al.
IMMUNOLOGY (2006)
A role for BLyS in the activation of innate immune cells
Sock Kyung Chang et al.
BLOOD (2006)
Regulation of T:B cell interactions by the Inducible Costimulator molecule:: Does ICOS induce disease?
Rebecca A. Shilling et al.
CLINICAL IMMUNOLOGY (2006)
Type-I interferons and systemic lupus erythematosus
Sophie Koutouzov et al.
AUTOIMMUNITY REVIEWS (2006)
Unraveling the genetics of systemic lupus erythematosus
John B. Harley et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2006)
Selective dysregulation of the FcγIIB receptor on memory B cells in SLE
Meggan Mackay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus
Sean R. Christensen et al.
IMMUNITY (2006)
Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice
Robert Berland et al.
IMMUNITY (2006)
Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-γ and IL-17 secretion by activated human PBMC
John A. Meyers et al.
CYTOKINE (2006)
Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF
Chaim O. Jacob et al.
JOURNAL OF IMMUNOLOGY (2006)
ICOS-induced B7h shedding on B cells IsInhibited by TLR7/8 and TLR9
Eric C. Logue et al.
JOURNAL OF IMMUNOLOGY (2006)
Immunobiology of Toll-like receptors: Emerging trends
Saumya Pandey et al.
IMMUNOLOGY AND CELL BIOLOGY (2006)
Follicular B helper T cell activity is confined to CXCR5hiICOShi CD4 T cells and is independent of CD57 expression
Ata-Ur Rasheed et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication
Prapaporn Pisitkun et al.
SCIENCE (2006)
Novel therapeutics for systemic lupus erythematosus
Margrit Wiesendanger et al.
CURRENT OPINION IN RHEUMATOLOGY (2006)
TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE
M Ehlers et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Similarities and differences between selective and nonselective BAFF blockade in murine SLE
M Ramanujam et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
All is not Toll: new pathways in DNA recognition
H Wagner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis
MJ Leandro et al.
ARTHRITIS AND RHEUMATISM (2006)
Abetimus sodium (Riquent) for the prevention of nephritic flares in patients with systemic lupus erythematosus
R Furie
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2006)
Progression of kidney disease: Blocking leukocyte recruitment with chemokine receptor CCR1 antagonists
HJ Anders et al.
KIDNEY INTERNATIONAL (2006)
Toll-like receptor 9 signaling protects against murine lupus
XB Wu et al.
ARTHRITIS AND RHEUMATISM (2006)
Apoptosis and autoimmunity
Jeannine S. Navratil et al.
IMMUNOLOGIC RESEARCH (2006)
Fc gamma receptors: Old friends and new family members
F Nimmerjahn et al.
IMMUNITY (2006)
Targeting toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus
PS Lenert
ARTHRITIS RESEARCH & THERAPY (2006)
Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus
Thomas Doerner et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Type I inteferon gene induction by the interferon regulatory factor family of transcription factors
Kenya Honda et al.
IMMUNITY (2006)
Indoleamine 2,3 dioxygenase and regulation of T cell immunity
A Mellor
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement
CM Lau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cutting edge: Low-affinity, Smith antigen-speciftic B cells are tolerized by dendritic cells and macrophages
MA Kilmon et al.
JOURNAL OF IMMUNOLOGY (2005)
TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells
SR Krutzik et al.
NATURE MEDICINE (2005)
A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity
CG Vinuesa et al.
NATURE (2005)
Identification of proteoglycans as the APRIL-specific binding partners
K Ingold et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody
M Mihara et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
TNF pathophysiology in murine models of chronic inflammation and autoimmunity
G Kollias
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice
Y Hamaguchi et al.
JOURNAL OF IMMUNOLOGY (2005)
Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus
S Sigurdsson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
IFN-α induces early lethal lupus in preautoimmune (New Zealand black x New Zealand White)F1 but not in BALB/c mice
A Mathian et al.
JOURNAL OF IMMUNOLOGY (2005)
Natural serum IgM maintains immunological homeostasis and prevents autoimmunity
JJ Manson et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2005)
Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells
J Kim et al.
BLOOD (2005)
TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis
AM Tobin et al.
BIODRUGS (2005)
Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice
L Dong et al.
ARTHRITIS AND RHEUMATISM (2005)
Restoration of tolerance in lupus by targeted inhibitory receptor expression
TL McGaha et al.
SCIENCE (2005)
Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy
Q Gong et al.
JOURNAL OF IMMUNOLOGY (2005)
Rituximab anti-B-cell therapy in systemic lupus erythematosus: pointing to the future
PP Sfikakis et al.
CURRENT OPINION IN RHEUMATOLOGY (2005)
B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator
JR Sedy et al.
NATURE IMMUNOLOGY (2005)
The inhibitory Fc gamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G(+) anti-DNA plasma cells
H Fukuyama et al.
NATURE IMMUNOLOGY (2005)
4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells
BK Choi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF
R Lesley et al.
IMMUNITY (2004)
BCMA is essential for the survival of long-lived bone marrow plasma cells
BP O'Connor et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus
A Hutloff et al.
ARTHRITIS AND RHEUMATISM (2004)
Safety and efficacy of tumor necrosis factor α blockade in systemic lupus erythematosus -: An open-label study
M Aringer et al.
ARTHRITIS AND RHEUMATISM (2004)
Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner
M Rutz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus
M Ramanujam et al.
JOURNAL OF IMMUNOLOGY (2004)
CTLA4Ig prevents initiation but not evolution of anti-phospholipid syndrome in NZW/BXSB mice
A Akkerman et al.
AUTOIMMUNITY (2004)
Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: Phase I/II clinical trial results
JP Leonard et al.
CLINICAL CANCER RESEARCH (2004)
B cell depletion as a novel treatment for systemic lupus erythematosus - A phase I/II dose-escalation trial of rituximab
RJ Looney et al.
ARTHRITIS AND RHEUMATISM (2004)
The current status of targeting BAFF/BLyS for autoimmune diseases
M Ramanujam et al.
ARTHRITIS RESEARCH & THERAPY (2004)
The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy
JJ Uchida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide alone
RF van Vollenhoven et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2004)
Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches
M Thien et al.
IMMUNITY (2004)
Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli
KS Peterson et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus
JH Anolik et al.
ARTHRITIS AND RHEUMATISM (2004)
The role of FcγRIIA and IIIA polymorphisms in autoimmune diseases
FB Karassa et al.
BIOMEDICINE & PHARMACOTHERAPY (2004)
Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice
HJ Anders et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
The role of complement in the development of systemic lupus erythematosus
AP Manderson et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Rationale for interleukin-6 blockade in systemic lupus erythematosus
E Tackey et al.
LUPUS (2004)
Mouse CD20 expression and function
J Uchida et al.
INTERNATIONAL IMMUNOLOGY (2004)
Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients
PI Sidiropoulos et al.
LUPUS (2004)
Reprogramming of IL-10 activity and signaling by IFN-γ1
C Herrero et al.
JOURNAL OF IMMUNOLOGY (2003)
Timing of IFN-β exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation:: A role for IFN-β-mediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation
T Nagai et al.
JOURNAL OF IMMUNOLOGY (2003)
Development of autoantibodies before the clinical onset of systemic lupus erythematosus
MR Arbuckle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis
H Iwai et al.
JOURNAL OF IMMUNOLOGY (2003)
Predominant autoantibody production by early human B cell precursors
H Wardemann et al.
SCIENCE (2003)
Cutting edge: Induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion
AL Mellor et al.
JOURNAL OF IMMUNOLOGY (2003)
Cutting edge: Germinal centers formed in the absence of B cell-activating factor belonging to the TNF family exhibit impaired maturation and function
KA Vora et al.
JOURNAL OF IMMUNOLOGY (2003)
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice
MJI Ansari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
N Watanabe et al.
NATURE IMMUNOLOGY (2003)
Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition
L Schiffer et al.
JOURNAL OF IMMUNOLOGY (2003)
The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens
J Lohr et al.
NATURE IMMUNOLOGY (2003)
Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis
JD Ji et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
H Ueda et al.
NATURE (2003)
Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis
RR Singh et al.
JOURNAL OF IMMUNOLOGY (2003)
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
L Bennett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
EC Baechler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis
DT Boumpas et al.
ARTHRITIS AND RHEUMATISM (2003)
Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells
C Pasare et al.
SCIENCE (2003)
Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus
XB Wang et al.
ARTHRITIS AND RHEUMATISM (2003)
Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice
K Matsumoto et al.
ARTHRITIS AND RHEUMATISM (2003)
The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus
JH Anolik et al.
ARTHRITIS AND RHEUMATISM (2003)
LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus -: Results from a randomized, double-blind, placebo-controlled study
D Alarcón-Segovia et al.
ARTHRITIS AND RHEUMATISM (2003)
Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10
M Löhning et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Etanercept-induced systemic lupus erythematosus
VJ Swale et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2003)
Systemic lupus erythematosus and the type I interferon system
L Ronnblom et al.
ARTHRITIS RESEARCH & THERAPY (2003)
B cell abnormalities in systemic lupus erythematosus
AC Grammer et al.
ARTHRITIS RESEARCH & THERAPY (2003)
Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease
YL Sun et al.
NATURE MEDICINE (2002)
The natural interferon-α producing cells in systemic lupus erythematosus
L Rönnblom et al.
HUMAN IMMUNOLOGY (2002)
A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans
L Prokunina et al.
NATURE GENETICS (2002)
New regulatory co-receptors: inducible co-stimulator and PD-1
T Okazaki et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154 - A randomized, double-blind, placebo-controlled trial
KC Kalunian et al.
ARTHRITIS AND RHEUMATISM (2002)
An open study of B lymphocyte depletion in systemic lupus erythematosus
MJ Leandro et al.
ARTHRITIS AND RHEUMATISM (2002)
Tumor necrosis factor family ligands and receptors in the immune system: Targets for future pharmaceuticals
FKM Chan et al.
DRUG NEWS & PERSPECTIVES (2002)
Costimulatory blockade in patients with rheumatoid arthritis a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion
LW Moreland et al.
ARTHRITIS AND RHEUMATISM (2002)
The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus
WQ Huang et al.
ARTHRITIS AND RHEUMATISM (2002)
Negative co-receptors on lymphocytes
RJ Greenwald et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Mechanism of action of combined short-term CTLA4Ig and Anti-CD40 ligand in murine systemic lupus erythematosus
XB Wang et al.
JOURNAL OF IMMUNOLOGY (2002)
Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis
E Romas et al.
BONE (2002)
An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway
B Schiemann et al.
SCIENCE (2001)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)
Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: Implications for pathogenesis and therapy of autoimmune demyelination
G Kassiotis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
ICOS co-stimulatory receptor is essential for T-cell activation and function
C Dong et al.
NATURE (2001)
ICOS is critical for CD40-mediated antibody class switching
AJ McAdam et al.
NATURE (2001)
Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus
J Zhang et al.
JOURNAL OF IMMUNOLOGY (2001)
Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis
S Bolland et al.
IMMUNITY (2000)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
RA Clynes et al.
NATURE MEDICINE (2000)
分享论文
